DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Kaczirek K, Ciuleanu TE, Vrbanec D. et al.
FOLFOX4 plus cetuximab for patients with previously untreated metastatic colorectal cancer according to tumor RAS and BRAF mutation status: updated analysis of the CECOG/CORE 1.2.002 study.
Clin Colorectal Cancer 2015;
14 (02) 91-98
We do not assume any responsibility for the contents of the web pages of other providers.